Literature DB >> 26886433

Patient-provider communication with HIV-positive women about abnormal Pap test results.

Lisa T Wigfall1,2, Shalanda A Bynum3, Daniela B Friedman4,5, Heather M Brandt4,5, Donna L Richter4, Saundra H Glover1,2, James R Hébert4,6.   

Abstract

In this article, the authors examine communication between women living with human immunodeficiency virus (WLH) and health care providers (HCPs) regarding abnormal Pap tests. During the period of March 2011 through April 2012, 145 WLH were recruited from Ryan White funded clinics and community-based AIDS service organizations located in the southeastern United States. WLH who had an abnormal Pap test (69%, n = 100/145) were asked if their HCP shared and explained information about abnormal Pap tests. The authors performed chi-square tests and multivariable logistic regression analyses using Stata I/C 13. HCPs shared information about abnormal Pap tests with 60% of participants, and explained the information they shared to 78% of those. Health literate participants were more than three times as likely to have read the information received about abnormal Pap tests (adjusted odds ratio [aOR] = 3.49, 95% confidence interval [CI] 1.19-10.23), and almost five times as likely to have understood the cancer information they read (aOR = 4.70, 95% CI 1.55-14.24). Knowing other women who had had an abnormal Pap test was not significantly associated with cancer information seeking or processing after controlling for confounding factors. The present findings underscore the need to increase WLH's health literacy as an intermediate step to improving patient-provider communication among WLH. Lay sources of cancer information for WLH warrant further study.

Entities:  

Keywords:  Cervical cancer; HIV; HPV; health literacy; information seeking

Mesh:

Year:  2016        PMID: 26886433      PMCID: PMC4988935          DOI: 10.1080/03630242.2016.1150386

Source DB:  PubMed          Journal:  Women Health        ISSN: 0363-0242


  25 in total

1.  HIV testing in women: missed opportunities.

Authors:  Wayne A Duffus; Harley T Davis; Michael D Byrd; Khosrow Heidari; Terri G Stephens; James J Gibson
Journal:  J Womens Health (Larchmt)       Date:  2011-09-27       Impact factor: 2.681

2.  Analysis of 2 x 2 tables of frequencies: matching test to experimental design.

Authors:  John Ludbrook
Journal:  Int J Epidemiol       Date:  2008-08-18       Impact factor: 7.196

3.  Effects of a treatment adherence enhancement program on health literacy, patient-provider relationships, and adherence to HAART among low-income HIV-positive Spanish-speaking Latinos.

Authors:  Gwen van Servellen; Adeline Nyamathi; Felix Carpio; Daniel Pearce; Lorraine Garcia-Teague; Gilberto Herrera; Emilia Lombardi
Journal:  AIDS Patient Care STDS       Date:  2005-11       Impact factor: 5.078

4.  Trends in cancer risk among people with AIDS in the United States 1980-2002.

Authors:  Eric A Engels; Ruth M Pfeiffer; James J Goedert; Phillip Virgo; Timothy S McNeel; Steven M Scoppa; Robert J Biggar
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

5.  HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?

Authors:  Mark Bower; Tom Powles; Tom Newsom-Davis; Christina Thirlwell; Justin Stebbing; Sundihya Mandalia; Mark Nelson; Brian Gazzard
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-15       Impact factor: 3.731

6.  Cancer risk in people infected with human immunodeficiency virus in the United States.

Authors:  Eric A Engels; Robert J Biggar; H Irene Hall; Helene Cross; Allison Crutchfield; Jack L Finch; Rebecca Grigg; Tara Hylton; Karen S Pawlish; Timothy S McNeel; James J Goedert
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

Review 7.  Non-AIDS-defining cancers among HIV-infected people.

Authors:  M R Pinzone; F Fiorica; M Di Rosa; G Malaguarnera; L Malaguarnera; B Cacopardo; G Zanghì; G Nunnari
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-10       Impact factor: 3.507

8.  Prevalence of cervical cancer screening of HIV-infected women in the United States.

Authors:  Alexandra M Oster; Patrick S Sullivan; Janet M Blair
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-01       Impact factor: 3.731

Review 9.  HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy.

Authors:  Hugo De Vuyst; Flavia Lillo; Nathalie Broutet; Jennifer S Smith
Journal:  Eur J Cancer Prev       Date:  2008-11       Impact factor: 2.497

10.  Assessing the influence of health literacy on HIV-positive women's cervical cancer prevention knowledge and behaviors.

Authors:  Shalanda A Bynum; Lisa T Wigfall; Heather M Brandt; Donna L Richter; Saundra H Glover; James R Hébert
Journal:  J Cancer Educ       Date:  2013-06       Impact factor: 2.037

View more
  4 in total

Review 1.  Knowledge of HPV/cervical cancer and acceptability of HPV self-sampling among women living with HIV: A scoping review.

Authors:  J P H Wong; M Vahabi; J Miholjcic; V Tan; M Owino; A T W Li; M K L Poon
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

Review 2.  Recruitment and Retention of Women Living With HIV for Clinical Research: A Review.

Authors:  Kyra Jennifer Waligora Mendez; Joycelyn Cudjoe; Sarah Strohmayer; Hae-Ra Han
Journal:  AIDS Behav       Date:  2021-05-14

3.  HPV-Related Cancer Prevention and Control Programs at Community-Based HIV/AIDS Service Organizations: Implications for Future Engagement.

Authors:  Lisa T Wigfall; Shalanda A Bynum; Heather M Brandt; Neethu Sebastian; Marcia G Ory
Journal:  Front Oncol       Date:  2018-10-26       Impact factor: 6.244

4.  HPV knowledge, screening barriers and facilitators, and sources of health information among women living with HIV: perspectives from the DC community during the COVID-19 pandemic.

Authors:  Annie Coriolan Ciceron; Min Jeong Jeon; Anne Kress Monroe; Michelle Elise Clausen; Manya Magnus; Daisy Le
Journal:  BMC Womens Health       Date:  2022-04-09       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.